<?xml version="1.0" encoding="UTF-8"?>
<p>No significant difference was observed in AAR/LV (%) between the vehicle- and RosA-treated groups, indicating that a comparable degree of ischaemic jeopardy was present between the groups following occlusion of the left anterior descending artery (LAD; 
 <xref ref-type="fig" rid="F0002">Figure 2(B)</xref>). However, treatment with 100 mg/kg RosA significantly reduced the IS/AAR (%) compared to the I/R + Vehicle group (24.83 ± 6.46% vs. 39.33 ± 5.61%, 
 <xref ref-type="fig" rid="F0002">Figure 2(C)</xref>).
</p>
